Interventional Vascular Consumables Market Research Report 2022 – Global Analysis, Revenue Estimation and Forecasts to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Interventional Vascular Consumables Market Research Report: By Type, Product Type – Revenue Estimation and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. From an estimated $3,929.2 million in 2021, the interventional vascular consumables market revenue is predicted to grow to $5,501.7 million by 2030, at a CAGR of 3.8%. Since interventional … [Read more…]

Royal Dental in Houston Joins Brident Dental & Orthodontics

HOUSTON–(BUSINESS WIRE)–Brident Dental & Orthodontics, a member of the Sonrava Health family of wellness companies, today announced that it has completed the acquisition of Royal Dental. With the Royal Dental locations, Brident and its affiliates now have 50 offices in the Houston area and 130 in Texas. Altogether, Sonrava Health dental affiliates, including Brident Dental … [Read more…]

Oola Announces New Partnership with the Association of California Nurse Leaders

These nursing professionals can now easily access the Oola Lifestyle Framework SACRAMENTO–(BUSINESS WIRE)–Groundbreaking self-development company Oola recently formed a partnership with the Association of California Nurse Leaders (ACNL). This unique relationship provides nurses within the organization with discounted access to the digital Oola Lifestyle Framework as well as other self-improvement digital courses offered by Oola. … [Read more…]

SYNAPS Dx Honors Researchers, Providers, Patients and Families During World Alzheimer’s Month

ROCKVILLE, Md.–(BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), recognizes World Alzheimer’s Month and the extraordinary progress in diagnosing the disease. The company’s DISCERN™ test assesses the factors directly related to the formation of synaptic connections in the brain impacting … [Read more…]

Prostate Cancer Nuclear Medicine Diagnostics Markets, 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type, PET Product, and End User” report has been added to ResearchAndMarkets.com’s offering. The global prostate cancer nuclear medicine diagnostics market is expected to grow from US$ 720.12 million in 2022 to US$ 1,315.66 million by 2028. … [Read more…]

External Defibrillator Market Research Report 2022 – Global Industry Revenue Forecast to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “External Defibrillator Market Research Report: By Patient Type, End User – Global Industry Revenue Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. One of the key reasons behind the growth of the global external defibrillator market is the rise in the prevalence of cardiovascular diseases (CVDs). As a result, the revenue … [Read more…]

Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to two upcoming webcasts of Pfizer discussions at healthcare conferences: Mikael Dolsten, Chief Scientific Officer, President, Worldwide Research, Development and Medical, at Citi’s 17th Annual BioPharma Conference on Wednesday, September 7, 2022 at 10:30 a.m. EDT; and David Denton, … [Read more…]

RudderStack Announces HIPAA-Compliant Customer Data Solution

SAN FRANCISCO–(BUSINESS WIRE)–RudderStack today announced HIPAA compliance, giving healthcare companies an easier way to manage and protect customer data. As a compliant solution provider, RudderStack can sign a Business Associate Agreement (BAA) with healthcare customers. RudderStack enables teams to collect, transform, and activate customer data across their stack, leveraging their own cloud data warehouse as … [Read more…]

Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market 2022-2028: Emergence of New Diagnostic Technologies & Growing Number of Pipeline Drugs Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. MARKET OUTLOOK This report states that the Alzheimer’s disease therapeutics and diagnostics market in the Asia-Pacific would fast progress with a CAGR of 12.18% over the forecast duration from 2022 to 2028. Japan, India, South Korea, China, Australia … [Read more…]

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union

CHMP recommendation based on safety, tolerability, and immunogenicity data from a Phase 2/3 trial of the Omicron BA.1-adapted bivalent vaccine The Omicron BA.1-adapted bivalent COVID-19 vaccine combines 15-µg of mRNA encoding the SARS-CoV-2 wild-type spike protein which is in the Original Pfizer-BioNTech COVID-19 Vaccine with 15-µg of mRNA encoding the spike protein of the Omicron … [Read more…]